Daniel Folch-Sanchez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Daniel Folch-Sanchez has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Joan Ignasi Mestre-Pinto
Addiction Research Group (GRAd), Neuroscience Research Program, Hospital del Mar Research Institute, 08003 Barcelona, Spain
3 shared publications - Laia Miquel
Grupo de Investigación en Salud y Adicciones (Grupo de Investigación Emergente), Instituto de Investigaciones Biomédicas August Pi I Sunyer (IDIBAPS), Barcelona. Unidad de Conductas Adictivas, Servicio de Psiquiatría y Psicología, Instituto de Neurociencias, Hospital Clínic de Barcelona, Barcelona, Cataluña.
3 shared publications - Maria Pellicer-Roca
Red de Investigación en Atención Primaria en Adicciones (RIAPAd), Spain
3 shared publications Chrysanthi Blithikioti
University of Padova, Padova, Italy
2 shared publications- Clara Mercadé
Parc de Salut Mar, Institut de Neuropsiquiatria i Adiccions (INAD), Barcelona, Spain
2 shared publications - Estefania Lopez Montes
Parc de Salut Mar, Institut de Neuropsiquiatria i Adiccions (INAD), Barcelona, Spain
2 shared publications
Latest Publications
- Open Access
- 20 October 2026
- Published by SAGE Publications in Journal of Experimental Psychopathology
- Vol. 17 (4)
Concurrent Cognitive Tasks and Early Extinction Dynamics in Eyeblink Conditioning: An Exploratory Study
Introduction: Concurrent cognitive tasks can influence memory processing by interfering with ongoing cognitive operations. Although such effects have been widely studied using subjective measures, their impact on objective indices of extinction learning remains unclear. Methods: Eighty-four healthy participants were randomly assigned to perform eye-movements (EMs), the Trail Making Test Part B (TMT-B), or no-task control condition during the initial extinction trials of an eyeblink conditioning (EBC) task. Conditioned responses (CRs), CR onset latency and amplitude, and unconditioned responses (URs) were examined across acquisition and extinction. Results: In the first extinction block, the TMT-B group showed higher CR probability and shorter CR onset latency than the EM group. Neither CR probability nor CR onset latency differed significantly between the TMT-B and control groups or between the EM and control groups. Discussion: Under the present experimental conditions, brief EMs were not associated with detectable changes relative to control, whereas TMT-B performance was associated with a short-lived alteration in early response dynamics. The results indicate a transient divergence in early extinction-related responding across task conditions, but the differences were confined to the first extinction block and were not consistent across outcome measures or comparisons with the control condition.
- 20 October 2026
- Published by SAGE Publications in Journal of Experimental Psychopathology
- Vol. 17 (4)
Open AccessConcurrent Cognitive Tasks and Early Extinction Dynamics in Eyeblink Conditioning: An Exploratory Study
Introduction: Concurrent cognitive tasks can influence memory processing by interfering with ongoing cognitive operations. Although such effects have been widely studied using subjective measures, their impact on objective indices of extinction learning remains unclear. Methods: Eighty-four healthy participants were randomly assigned to perform eye-movements (EMs), the Trail Making Test Part B (TMT-B), or no-task control condition during the initial extinction trials of an eyeblink conditioning (EBC) task. Conditioned responses (CRs), CR onset latency and amplitude, and unconditioned responses (URs) were examined across acquisition and extinction. Results: In the first extinction block, the TMT-B group showed higher CR probability and shorter CR onset latency than the EM group. Neither CR probability nor CR onset latency differed significantly between the TMT-B and control groups or between the EM and control groups. Discussion: Under the present experimental conditions, brief EMs were not associated with detectable changes relative to control, whereas TMT-B performance was associated with a short-lived alteration in early response dynamics. The results indicate a transient divergence in early extinction-related responding across task conditions, but the differences were confined to the first extinction block and were not consistent across outcome measures or comparisons with the control condition.
- Open Access
- 3 July 2025
- Published by Wiley in Psychology and Psychotherapy: Theory, Research and Practice
- Vol. 98 (4) , 1005-1016
Disentangling eye movement desensitization and reprocessing mechanisms of action: The impact of eye movements in the eye blink conditioning task
Objectives: Eye movement desensitization and reprocessing (EMDR) is an effective evidence‐based treatment for post‐traumatic stress disorder. However, the therapeutic mechanisms underlying eye movements (EM) remain unclear. This study aimed to investigate the effect of horizontal EM on fear extinction learning in healthy individuals, using an Eye Blink Conditioning (EBC) task. This experimental paradigm has been widely used to explore associative fear learning and memory as a form of classical conditioning. Methods: Healthy participants were included to the study protocol and divided randomly into two groups. The EM group ( n = 20) were asked to follow horizontally the experimenter's moving finger at the beginning of the extinction phase and the control group ( n = 19) did not engage in any specific task. Sociodemographic and clinical information was collected. Percentage of conditioned response (CR) occurrence, time of onset and intensity between and within groups over longitudinal time were analysed using generalized multilevel mixed effects for repeated measures. Results: Results showed accelerated extinction learning in the EM group, with an 18.2% probability of CR occurrence in the first block of extinction, compared to the control group (40.9%) ( p ‐value = .007). Conclusions: The findings indicate that horizontal EM accelerates the extinction process in the EBC task. Therefore, this paradigm, used for studying associative learning and memory, could serve as an objective measure to investigate the mechanisms of action involved in desensitizing traumatic experiences during EMDR treatment.
- 3 July 2025
- Published by Wiley in Psychology and Psychotherapy: Theory, Research and Practice
- Vol. 98 (4) , 1005-1016
Open AccessDisentangling eye movement desensitization and reprocessing mechanisms of action: The impact of eye movements in the eye blink conditioning task
Objectives: Eye movement desensitization and reprocessing (EMDR) is an effective evidence‐based treatment for post‐traumatic stress disorder. However, the therapeutic mechanisms underlying eye movements (EM) remain unclear. This study aimed to investigate the effect of horizontal EM on fear extinction learning in healthy individuals, using an Eye Blink Conditioning (EBC) task. This experimental paradigm has been widely used to explore associative fear learning and memory as a form of classical conditioning. Methods: Healthy participants were included to the study protocol and divided randomly into two groups. The EM group ( n = 20) were asked to follow horizontally the experimenter's moving finger at the beginning of the extinction phase and the control group ( n = 19) did not engage in any specific task. Sociodemographic and clinical information was collected. Percentage of conditioned response (CR) occurrence, time of onset and intensity between and within groups over longitudinal time were analysed using generalized multilevel mixed effects for repeated measures. Results: Results showed accelerated extinction learning in the EM group, with an 18.2% probability of CR occurrence in the first block of extinction, compared to the control group (40.9%) ( p ‐value = .007). Conclusions: The findings indicate that horizontal EM accelerates the extinction process in the EBC task. Therefore, this paradigm, used for studying associative learning and memory, could serve as an objective measure to investigate the mechanisms of action involved in desensitizing traumatic experiences during EMDR treatment.
- Open Access
- 19 March 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27, e65025
Evaluating Perceptions of the CANreduce 2.0 eHealth Intervention for Cannabis Use: Focus Group Study
Background: Cannabis is the most widely used illicit drug, and admissions for cannabis use disorders (CUDs) are increasing globally, posing a significant public health challenge. Despite its negative consequences, a substantial proportion of individuals with problematic use do not seek treatment. In recent years, digital health interventions (DHIs) have emerged as accessible and cost-effective solutions, empowering users to manage their health care. CANreduce is one such eHealth intervention that has demonstrated effectiveness in reducing cannabis use (CU); however, its suboptimal adherence rates underscore the need for strategies to enhance user engagement and motivation. Objective: This study aims to improve the effectiveness, adherence, and user experience of the Spanish version of CANreduce 2.0 by employing focus groups (FGs) within a user-centered design approach that actively involves both users and professionals. Methods: Separate FGs were conducted for users and professionals, involving a total of 10 participants. Users were recruited from individuals registered on the CANreduce 2.0 platform and active cannabis users, while professionals comprised addiction specialists familiar with the platform. Each session was held remotely and moderated by 2 interviewers following a semistructured script. Qualitative analysis of the transcripts was performed using MAXQDA software and content analysis methodology to identify key themes related to the acceptability, usability, and utility of CANreduce 2.0. Results: The qualitative analysis identified 3 main themes, encompassing 15 subcodes. Within the “motivation and awareness” theme, both users (n=6, mean age 31.8 years, SD 4.1 years) and professionals (n=4, mean age 37.25 years, SD 1.71 years) frequently discussed the importance of “motivation” and “problem awareness” as crucial for the success of CANreduce 2.0. In the “guidance and use” theme, the subcode “complement to face-to-face therapy” was the most emphasized. Professionals supported CANreduce 2.0 as a valuable adjunct to in-person therapy, serving as both an educational and monitoring tool, with no objections raised by either group. Lastly, within the “content and design” theme, “information,” “small achievements,” and “personalized content” emerged as key areas for improvement, highlighting the need to enhance motivation and adherence through gamification and tailored content. Conclusions: Personalization, robust motivational strategies, and an engaging, interactive design are essential for the success of DHIs, particularly in addiction treatment. Collaboration among technology developers, health care professionals, and users should be central to the development process, fostering the cocreation of practical and effective solutions that are responsive to the needs of those seeking treatment. This approach ensures that DHIs are not only functional but also widely accepted and impactful. Insights from this study will inform the ongoing refinement of CANreduce 2.0, enhancing its relevance and effectiveness in addressing CU.
- 19 March 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27, e65025
Open AccessEvaluating Perceptions of the CANreduce 2.0 eHealth Intervention for Cannabis Use: Focus Group Study
Background: Cannabis is the most widely used illicit drug, and admissions for cannabis use disorders (CUDs) are increasing globally, posing a significant public health challenge. Despite its negative consequences, a substantial proportion of individuals with problematic use do not seek treatment. In recent years, digital health interventions (DHIs) have emerged as accessible and cost-effective solutions, empowering users to manage their health care. CANreduce is one such eHealth intervention that has demonstrated effectiveness in reducing cannabis use (CU); however, its suboptimal adherence rates underscore the need for strategies to enhance user engagement and motivation. Objective: This study aims to improve the effectiveness, adherence, and user experience of the Spanish version of CANreduce 2.0 by employing focus groups (FGs) within a user-centered design approach that actively involves both users and professionals. Methods: Separate FGs were conducted for users and professionals, involving a total of 10 participants. Users were recruited from individuals registered on the CANreduce 2.0 platform and active cannabis users, while professionals comprised addiction specialists familiar with the platform. Each session was held remotely and moderated by 2 interviewers following a semistructured script. Qualitative analysis of the transcripts was performed using MAXQDA software and content analysis methodology to identify key themes related to the acceptability, usability, and utility of CANreduce 2.0. Results: The qualitative analysis identified 3 main themes, encompassing 15 subcodes. Within the “motivation and awareness” theme, both users (n=6, mean age 31.8 years, SD 4.1 years) and professionals (n=4, mean age 37.25 years, SD 1.71 years) frequently discussed the importance of “motivation” and “problem awareness” as crucial for the success of CANreduce 2.0. In the “guidance and use” theme, the subcode “complement to face-to-face therapy” was the most emphasized. Professionals supported CANreduce 2.0 as a valuable adjunct to in-person therapy, serving as both an educational and monitoring tool, with no objections raised by either group. Lastly, within the “content and design” theme, “information,” “small achievements,” and “personalized content” emerged as key areas for improvement, highlighting the need to enhance motivation and adherence through gamification and tailored content. Conclusions: Personalization, robust motivational strategies, and an engaging, interactive design are essential for the success of DHIs, particularly in addiction treatment. Collaboration among technology developers, health care professionals, and users should be central to the development process, fostering the cocreation of practical and effective solutions that are responsive to the needs of those seeking treatment. This approach ensures that DHIs are not only functional but also widely accepted and impactful. Insights from this study will inform the ongoing refinement of CANreduce 2.0, enhancing its relevance and effectiveness in addressing CU.
- Open Access
- 5 August 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Evaluating Perceptions of the CANreduce 2.0 eHealth Intervention for Cannabis Use: Focus Group Study (Preprint)
BACKGROUND Cannabis is the most widely used illicit drug, and admissions for cannabis use disorders (CUDs) are increasing globally, posing a significant public health challenge. Despite its negative consequences, a substantial proportion of individuals with problematic use do not seek treatment. In recent years, digital health interventions (DHIs) have emerged as accessible and cost-effective solutions, empowering users to manage their health care. CANreduce is one such eHealth intervention that has demonstrated effectiveness in reducing cannabis use (CU); however, its suboptimal adherence rates underscore the need for strategies to enhance user engagement and motivation. OBJECTIVE This study aims to improve the effectiveness, adherence, and user experience of the Spanish version of CANreduce 2.0 by employing focus groups (FGs) within a user-centered design approach that actively involves both users and professionals. METHODS Separate FGs were conducted for users and professionals, involving a total of 10 participants. Users were recruited from individuals registered on the CANreduce 2.0 platform and active cannabis users, while professionals comprised addiction specialists familiar with the platform. Each session was held remotely and moderated by 2 interviewers following a semistructured script. Qualitative analysis of the transcripts was performed using MAXQDA software and content analysis methodology to identify key themes related to the acceptability, usability, and utility of CANreduce 2.0. RESULTS The qualitative analysis identified 3 main themes, encompassing 15 subcodes. Within the “motivation and awareness” theme, both users (n=6, mean age 31.8 years, SD 4.1 years) and professionals (n=4, mean age 37.25 years, SD 1.71 years) frequently discussed the importance of “motivation” and “problem awareness” as crucial for the success of CANreduce 2.0. In the “guidance and use” theme, the subcode “complement to face-to-face therapy” was the most emphasized. Professionals supported CANreduce 2.0 as a valuable adjunct to in-person therapy, serving as both an educational and monitoring tool, with no objections raised by either group. Lastly, within the “content and design” theme, “information,” “small achievements,” and “personalized content” emerged as key areas for improvement, highlighting the need to enhance motivation and adherence through gamification and tailored content. CONCLUSIONS Personalization, robust motivational strategies, and an engaging, interactive design are essential for the success of DHIs, particularly in addiction treatment. Collaboration among technology developers, health care professionals, and users should be central to the development process, fostering the cocreation of practical and effective solutions that are responsive to the needs of those seeking treatment. This approach ensures that DHIs are not only functional but also widely accepted and impactful. Insights from this study will inform the ongoing refinement of CANreduce 2.0, enhancing its relevance and effectiveness in addressing CU.
- 5 August 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessEvaluating Perceptions of the CANreduce 2.0 eHealth Intervention for Cannabis Use: Focus Group Study (Preprint)
BACKGROUND Cannabis is the most widely used illicit drug, and admissions for cannabis use disorders (CUDs) are increasing globally, posing a significant public health challenge. Despite its negative consequences, a substantial proportion of individuals with problematic use do not seek treatment. In recent years, digital health interventions (DHIs) have emerged as accessible and cost-effective solutions, empowering users to manage their health care. CANreduce is one such eHealth intervention that has demonstrated effectiveness in reducing cannabis use (CU); however, its suboptimal adherence rates underscore the need for strategies to enhance user engagement and motivation. OBJECTIVE This study aims to improve the effectiveness, adherence, and user experience of the Spanish version of CANreduce 2.0 by employing focus groups (FGs) within a user-centered design approach that actively involves both users and professionals. METHODS Separate FGs were conducted for users and professionals, involving a total of 10 participants. Users were recruited from individuals registered on the CANreduce 2.0 platform and active cannabis users, while professionals comprised addiction specialists familiar with the platform. Each session was held remotely and moderated by 2 interviewers following a semistructured script. Qualitative analysis of the transcripts was performed using MAXQDA software and content analysis methodology to identify key themes related to the acceptability, usability, and utility of CANreduce 2.0. RESULTS The qualitative analysis identified 3 main themes, encompassing 15 subcodes. Within the “motivation and awareness” theme, both users (n=6, mean age 31.8 years, SD 4.1 years) and professionals (n=4, mean age 37.25 years, SD 1.71 years) frequently discussed the importance of “motivation” and “problem awareness” as crucial for the success of CANreduce 2.0. In the “guidance and use” theme, the subcode “complement to face-to-face therapy” was the most emphasized. Professionals supported CANreduce 2.0 as a valuable adjunct to in-person therapy, serving as both an educational and monitoring tool, with no objections raised by either group. Lastly, within the “content and design” theme, “information,” “small achievements,” and “personalized content” emerged as key areas for improvement, highlighting the need to enhance motivation and adherence through gamification and tailored content. CONCLUSIONS Personalization, robust motivational strategies, and an engaging, interactive design are essential for the success of DHIs, particularly in addiction treatment. Collaboration among technology developers, health care professionals, and users should be central to the development process, fostering the cocreation of practical and effective solutions that are responsive to the needs of those seeking treatment. This approach ensures that DHIs are not only functional but also widely accepted and impactful. Insights from this study will inform the ongoing refinement of CANreduce 2.0, enhancing its relevance and effectiveness in addressing CU.
- 20 July 2024
- Published by Springer Nature in CNS Drugs
- Vol. 38 (10) , 771-789
Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges
Mental health disorders and substance use disorders (SUDs) in particular, contribute greatly to the global burden of disease. Psychedelics, including entactogens and dissociative substances, are currently being explored for the treatment of SUDs, yet with less empirical clinical evidence than for other mental health disorders, such as depression or post-traumatic stress disorder (PTSD). In this narrative review, we discuss the current clinical research evidence, therapeutic potential and safety of psilocybin, lysergic acid diethylamide (LSD), ketamine, 3,4-methylenedioxymethamphetamine (MDMA) and ibogaine, particularly in the context of the SUD treatment. Our aim was to provide a balanced overview of the current research and findings on potential benefits and harms of psychedelics in clinical settings for SUD treatment. We highlight the need for more clinical research in this particular treatment area and point out some limitations and challenges to be addressed in future research.
- 20 July 2024
- Published by Springer Nature in CNS Drugs
- Vol. 38 (10) , 771-789
Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges
Mental health disorders and substance use disorders (SUDs) in particular, contribute greatly to the global burden of disease. Psychedelics, including entactogens and dissociative substances, are currently being explored for the treatment of SUDs, yet with less empirical clinical evidence than for other mental health disorders, such as depression or post-traumatic stress disorder (PTSD). In this narrative review, we discuss the current clinical research evidence, therapeutic potential and safety of psilocybin, lysergic acid diethylamide (LSD), ketamine, 3,4-methylenedioxymethamphetamine (MDMA) and ibogaine, particularly in the context of the SUD treatment. Our aim was to provide a balanced overview of the current research and findings on potential benefits and harms of psychedelics in clinical settings for SUD treatment. We highlight the need for more clinical research in this particular treatment area and point out some limitations and challenges to be addressed in future research.